Both in Pharmaceuticals
Briacell Therapeutics vs Biote
Over the past year BCTX returned −62.3% and BTMD returned −58.5%; their daily moves had a correlation of 0.06.
BCTX −62.3% BTMD −58.5%Growth of $1, one year, split-adjusted
| Metric | BCTX | BTMD |
|---|---|---|
| Price | $4.08 | $1.24 |
| Market cap | $35.5M | $35.6M |
| Today | −1.81% | +0.81% |
| 1 month | +9.4% | −21.0% |
| 6 months | −1.2% | −4.6% |
| Year to date | −42.6% | −52.3% |
| 1 year | −63.0% | −58.5% |
| Revenue growth (YoY) | — | −9.5% |
| Gross margin | — | 65.4% |
| Net margin | — | −14.8% |
| P/E (TTM) | — | 6.1× |
| Price / sales | — | 0.2× |
| Net cash | $22.8M | -$110.3M |
| Dividend yield | — | — |
| Volatility (60d) | 77.3% | 96.1% |
| Short % of float | 11.2% | 5.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).